Antonuzzo, L., Giommoni, E., Pastorelli, D., Latiano, T., Pavese, I., Azzarello, D., . . . Di Costanzo, F. (2015). Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study. World J Gastroenterol.
Styl cytowania ChicagoAntonuzzo, Lorenzo, et al. "Bevacizumab Plus XELOX As First-line Treatment of Metastatic Colorectal Cancer: The OBELIX Study." World J Gastroenterol 2015.
Styl cytowania MLAAntonuzzo, Lorenzo, et al. "Bevacizumab Plus XELOX As First-line Treatment of Metastatic Colorectal Cancer: The OBELIX Study." World J Gastroenterol 2015.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..